|
Trial no.:
|
PACTR202506793306194 |
Date of Registration:
|
06/06/2025 |
|
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
| TRIAL DESCRIPTION |
|
Public title
|
Zinc Oxide Ozonated Oil Versus Modified Triple Antibiotic Paste as a Lesion Sterilization and Tissue Repair Technique in Primary Molars |
| Official scientific title |
Effect of zinc oxide-ozonated olive oil (ZnO-OO) versus Modified Triple Antibiotic Paste (MTAP) as a Lesion Sterilization and Tissue Repair Technique in Primary Molars |
|
Brief summary describing the background
and objectives of the trial
|
Preservation of primary dentition is crucial for the development of arch form, esthetics, function, mastication, and normal eruption of permanent teeth. Premature loss, especially of the primary second molar, can cause several problems. The first permanent molars typically erupt mesially as a result, leading to some problems including the ectopic eruption of the second premolar, the loss of space for the succeeding permanent teeth and functional impairment. In the 1990s, an innovative procedure called lesion sterilization and tissue repair (LSTR) was proposed as an alternative biologic approach that was thought to facilitate the disinfection of dentinal carious lesions, pulp, and periapical lesions in primary teeth with the advantages of being simpler and faster. The LSTR is a minimally invasive endodontic therapy method that involves the introduction of an antibiotic combination in a propylene glycol vehicle to disinfect root canal systems and periapical lesions New generations of disinfecting agents have been developed among them is ozone, which is a powerful oxidizing agent and can be used to eliminate bacteria in root canals. This study aims to evaluate and compare the clinical and radiographic effects of zinc oxide-ozonated olive oil (ZnO-OO) versus Modified Triple Antibiotic Paste (MTAP) as a Lesion Sterilization and Tissue Repair Technique in Primary Molars.
|
| Type of trial |
RCT |
| Acronym (If the trial has an acronym then please provide) |
|
| Disease(s) or condition(s) being studied |
Oral Health |
| Sub-Disease(s) or condition(s) being studied |
|
| Purpose of the trial |
Treatment: Drugs |
| Anticipated trial start date |
01/11/2023 |
| Actual trial start date |
01/01/2024 |
| Anticipated date of last follow up |
30/06/2025 |
| Actual Last follow-up date |
|
| Anticipated target sample size (number of participants) |
60 |
| Actual target sample size (number of participants) |
|
| Recruitment status |
Closed to recruitment,follow-up continuing |
| Publication URL |
N/A |
|